HeartSciences (HSCS) Net Cash Flow (QoQ) (2021 - 2026)
HeartSciences (HSCS) Net Cash Flow (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | HeartSciences | 3.89 Mn | 492,884.20 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 271.90% |
| Oct 31, 2025 | -149.65% |
| Jul 31, 2025 | 213.06% |
| Apr 30, 2025 | -2.94% |
| Jan 31, 2025 | -406.02% |
| Oct 31, 2024 | 80.40% |
| Jul 31, 2024 | -15.69% |
| Apr 30, 2024 | -118.19% |
| Jan 31, 2024 | 1,567.13% |
| Oct 31, 2023 | 56.17% |
| Jul 31, 2023 | -301.06% |
| Apr 30, 2023 | 76.38% |
| Jan 31, 2023 | 4.31% |
| Oct 31, 2022 | -135.67% |
| Jul 31, 2022 | 918.21% |
| Apr 30, 2022 | -142.80% |
| Jan 31, 2022 | 224.71% |
| Oct 31, 2021 | -7.05% |